Dr. Michael J. Endl Among the First 20 Surgeons in the U.S. to Use the Newest OMNI Surgical System for Glaucoma

Dr. Michael J. Endl Offers the Newest OMNI Surgical System for Glaucoma Patients in Western New York

Fichte, Endl & Elmer Eyecare brings the latest implant-free glaucoma surgery technology to Western New York patients

BUFFALO, NY, UNITED STATES, November 10, 2026 /EINPresswire.com/ -- Michael J. Endl, M.D., of Fichte, Endl & Elmer Eyecare, is one of the first 20 surgeons in the United States to use the newest version of the OMNI Surgical System for the treatment of glaucoma. Dr. Endl performed the procedure during the week of September 28, giving patients in the Buffalo area early access to one of the most advanced minimally invasive glaucoma surgery (MIGS) technologies available.

Glaucoma is a leading cause of irreversible vision loss and often progresses without noticeable symptoms. In most cases, the disease is driven by elevated pressure inside the eye, which occurs when fluid cannot drain properly through the eye's natural drainage system. Over time, that pressure can damage the optic nerve. Many patients manage glaucoma with daily eye drops, but drops can be hard to keep up with and don't work for everyone.

The OMNI Surgical System takes a different approach. Rather than placing a stent or implant in the eye, OMNI restores the eye's own drainage pathways. This implant-free MIGS technology treats all three areas where fluid can become blocked: the trabecular meshwork, Schlemm's canal, and the collector channels. Addressing all three areas helps fluid flow out of the eye more naturally, lowering intraocular pressure.

The newest version of OMNI is the first FDA-cleared MIGS device that can perform a full canaloplasty in a single pass. Canaloplasty opens and expands the eye's drainage canal, and completing it in one pass gives surgeons greater efficiency and control during the procedure. The OMNI platform has already been used in more than 350,000 procedures worldwide.

"Treating glaucoma is about protecting a patient's vision for the long term, and that means using the most effective tools available," said Dr. Endl. "OMNI works with the eye's natural anatomy instead of leaving an implant behind, and this newest version lets us complete the full treatment more efficiently than ever. Being among the first surgeons in the country to use it means our patients benefit from the latest advances right here in Western New York."

OMNI is minimally invasive and can be performed on its own or at the same time as cataract surgery, making it a convenient option for patients who need both. For many patients, the procedure may reduce the need for daily glaucoma medications.
Dr. Endl has performed more than 40,000 cataract and refractive procedures and has been involved in multiple FDA trials.

Not every patient with glaucoma is a candidate for OMNI. The glaucoma specialists at Fichte, Endl & Elmer Eyecare evaluate each patient to recommend the most appropriate treatment.

Patients interested in learning whether OMNI is right for them can request an appointment online or call 1-800-309-2020.

Kathy Otto
Fichte, Endl & Elmer Eyecare
+1 716-282-1115
kathy.otto@fichte.com